Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical
TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement ...
Read moreDetails
Tag: Eisai
Eisai: Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024
Eisai: Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024TOKYO, Mar ...
Read moreDetails
The Earth News is an independent English-language daily published Website from all around the World News
